drugset / Trial / NCT05939778
A Study of TH-SC01 in the Treatment of Radiation-induced Rectal Injury
Phase 1
Unknown
27 enrolled
Jinling Hospital, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of allogeneic umbilical cord mesenchymal stem cells in the treatment of radiation-induced rectal injury.
Timeline
- Start
- 2022-09-21
- Primary completion
- 2024-01-21
- Completion
- 2026-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TH-SC01 | Cell therapy | 3e+07 cells | Other |
| Subject | TH-SC01 | Cell therapy | 6e+07 cells | Other |
| Subject | TH-SC01 | Cell therapy | 1.2e+08 cells | Other |
| Subject | TH-SC01 | Cell therapy | 2.4e+08 cells | Other |